Economic TimesLean R·
Lupin launches inhaler for COPD in India
New Delhi: Drug maker Lupin Ltd on Tuesday announced the launch of Formoflo-G MDI, a fixed-dose triple combination metered-dose inhaler (MDI) for the management of chronic obstructive pulmonary disease (COPD) in India.The launch follows approval from the Drug Controller General of India (DCGI), the company said in a statement.Formoflo-G MDI combines three established therapies- Glycopyrronium Bromide, Formoterol Fumarate, and Fluticasone Propionate-into a single inhaler for the long-term manage…
Read at Economic Times →
